{"id":"W2158862125","doi":"10.1056/nejmoa1213917","title":"Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":1433,"is_retracted":false,"has_abstract":true,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"Actelion Pharmaceuticals","keywords":"Medicine; Endothelin receptor antagonist; Pulmonary hypertension; Lung transplantation; Placebo; Bosentan; Clinical endpoint; Internal medicine; Cardiology; Hazard ratio; Confidence interval; Endothelin receptor; Anesthesia; Transplantation; Randomized controlled trial; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04315870017816357,"score_gpt":0.3016081234936187,"score_spread":0.2584494233154551,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}